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Introduction
Recurring primary headaches, such as migraine or ten-
sion-type, are common during childhood (2.5%) and ado-
lescence (15%) [1]. However, while ever increasing evi-
dence shows that migraine is a complex neurovascular
disorder with genetic factors playing a primary role in its
aetiology, none of the genetic factors which have to date
been shown to be linked to adult migraine susceptibility
have been investigated in children, for whom primary
headaches represent frequent causes for referral for neu-
rologic assessment. In addition, while epidemiological,
twin and family studies have revealed that approximately
one-half of its variation is attributable to additive genes,
with a negligible contribution of nonadditive genetic
effects [2], the identification and validation of the under-
lying genetic risk factors poses enormous challenges even
in adult migraine. The severity of migraine symptoms,
such as the recurrence and duration of attacks and the age
of onset, are variable among patients, thus rendering dif-
ficult both the definition of the appropriate phenotype as
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genes for migraine have been pro-
posed on the basis of their possible
functional role in its pathogenesis.
Genetic polymorphisms have been
evaluated in association studies,
some of which have been suggested
to be susceptibility markers for
adult migraine. To date, however,
none of the identified polymor-
phisms in adult migraine suscepti-
bility have been investigated in
children, raising the possibility that
they may not be necessarily
involved in paediatric migraine sus-
ceptibility. This paper reviews stud-
ies of the genetic basis of migraine
and summarises our experience in
genetic association studies in pri-
mary paediatric headache suscepti-
bility.
Key words Paediatric migraine •
Susceptibility • Polymorphism •
Endothelin type A receptor
Published online: 20 July 2005
180
well as the selection of the best population in which to
investigate the genetic load. Furthermore, some individu-
als may, independently of the presence or absence of envi-
ronmental influences or type of prophylactic therapy
undertaken, remain attack-free despite their genetic load,
while others will continue to suffer.
Given all this, the aim of the present paper is to pro-
vide a short overview of the current status of genetic sus-
ceptibility studies in migraine, herein including the prob-
lematics involved in their application in paediatric vs.
adult settings.
Genetic factors contribute to migraine
Genetic epidemiological studies of migraine show both
positive family history and increased disease risk in rela-
tives of migraine probands [3], the likelihood of which
increases when the age at onset in the proband is below 20
years [4]. However, while familiarity supports the impor-
tance of genetic factors in migraine susceptibility, it does
not prove heritability as it does not exclude the influences
of shared environmental factors and common lifestyles.
The significantly higher pairwise concordance rate among
monozygotic compared to dizygotic twin pairs better sup-
ports the importance of genetic factors with hereditability
estimates of about 50% for migraine without aura and with
aura [5]. In the case of tension-type headache, the genetic
factor may have a major role in the aetiopathogenesis of
chronic tension-type headache, whereas environmental
influence is stronger in episodic tension-type headache [6].
Molecular studies of the genetic factors in adult
migraine
Genome-wide scanning approaches have identified
migraine susceptibility loci on chromosomes 1, 4, 6, 11,
14, 19 and X [7]. By investigating familial hemiplegic
migraine (FHM), a rare Mendelian form of migraine with
aura transmitted by autosomal dominance [8], the identi-
fication of migraine genes such as the calcium channel
gene CACNA1A [9] and the α2 subunit of the Na+/K+
ATPase ATP1A2 gene [10, 11] was facilitated. In addition,
given the major statistical power to detect several genes of
small effect of the association studies by a candidate-gene
approach, the relationship between migraine and candi-
date genes involved in pathogenic theories has been
repeatedly investigated in adults [12]: unfortunately, the
results have not often been replicated in subsequent, inde-
pendent studies.
Do the genes identified in the adult migraine susceptibil-
ity explain susceptibility in children? Our experience
Given the increased familial risk in relatives of migraine
probands, we have, among the genes shown to be associat-
ed to adult migraine liability, recently focused on whether
the -231 G>A polymorphism in the endothelin 1 type A
receptor (EDNRA) shown to strongly modulate the risk of
adult migraine [13] contributes to paediatric migraine sus-
ceptibility. Results to date obtained, however, show that the
-231 G>A polymorphism in the EDNRA gene is neither
associated with primary juvenile headache nor significant-
ly correlated with main clinical features characteristic of
the headache pathology, thus suggesting the possibility of
an age-related interaction of the EDNRA polymorphic vari-
ant on migraine liability and disease expression [14].
Worth noting is that the only other published study
tackling the genetic aspects of juvenile migraine has,
based on evidence suggestive of an association between
migraine and prothrombotic genetic risk factors, consid-
ered the factor V Leiden mutation [15] due to its high
prevalence in patients with stroke and history of migraine
[16]. As in our experience, no difference in the prevalence
of this mutation was found in children and adolescents
with migraine with aura vs. controls.
Conclusive considerations
As migraine is characterised by wide phenotypic and, most
likely, genotypic heterogeneity, the identification and vali-
dation of the genetic risk factors involved critically depends
on the accuracy of the determination of the disease pheno-
type. However, although the recently revised International
Headache Society criteria (ICHD-II) have incorporated
many developmentally related sensitive changes allowing
for broader applicability in juvenile patients [17], the lack of
specific clinical and biological markers reduce the possibil-
ity to differentially classify paediatric patients and, hence,
the chance to identify the genetic risk factors involved. This
complexity, in addition, further increases when considering
the likelihood, of effects of “modifying” genes, as well as of
co-morbidity, including phenotypical heterochronia, togeth-
er with the possibility that the expression of the disease may
vary as a function of age. Thus, whilst the heterogeneous
complex traits of migraine may, in part, account for the cur-
rent discrepancies in genetic susceptibility studies conduct-
ed in adult and paediatric migraineurs, other factors includ-
ing comorbidity of migraine with other age-related disorders
sharing common similar pathways may be involved [18,
19], while environmental and individually related factors
may interact to raise the disease expression.
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In sum, although the identification and validation of
the genetic risk factors in primary headache susceptibility
introduce the possibility of identifying groups of patients
who possess particular diagnostic or prognostic character-
istics, it is particularly important to identify if and how
these advances apply in different clinical settings, herein
including the paediatric and adolescent settings, through
the design of appropriate clinical trials. Only in this way
it will be possible, at least on the basis of our attempts to
identify genetic susceptibility markers in primary paedi-
atric headache susceptibility based on those shown to be
associated to adult migraine liability, to ensure that the
resulting data are sufficiently robust in order to inform
clinical decision making and to revise the available treat-
ment strategies in primary headache disorders arising in
either the paediatric or adult stage.
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